CompoAtlas

・リフレのグルコサミンプレミアム: notification withdrawn

・リフレのグルコサミンプレミアム: notification withdrawn : Food with function claims notified in Japan. This notification does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

CAA, Japan Foods with Function Claims notifications, retrieval date unknown.

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

Registration number
E367
Type
Processed food (tablets, capsules and similar forms)
Published status
Notification withdrawn
Notifier
株式会社リフレ
Notification date
2019-08-30
Modification date
2023-08-05
Withdrawal date
2025-03-20

Notification under the company’s responsibility, without prior review by the Japanese state. The Japanese category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
グルコサミン塩酸塩グルコサミン塩酸塩 : 1,500mg (par jour)Chlorhydrate de glucosamine

Daily quantities are reproduced as declared, without estimation or conversion. A quantity is associated with an ingredient only when the name and match are unambiguous. Japanese names and texts are retained without translation. No comparison with dose limits is performed.

Name (original Japanese text)

グルコサミン塩酸塩含有食品

Declared claim (original Japanese text)

本品に含まれるグルコサミン塩酸塩には、膝関節の可動域を広げて膝の曲げ伸ばしの動きを助け、膝の不快な違和感を和らげる機能が報告されています。

Precautions (original Japanese text)

原材料を参照の上、食物アレルギーのある方は、お召し上がりにならないでください。血液凝固阻止薬(ワルファリン等)をご使用の場合は、医師、薬剤師に相談してください。

Reason for withdrawal (original Japanese text)

商品が終売になり在庫がなくなったため。

Raw materials of functional ingredients (original Japanese text)

原材料名:グルコサミン(えび・かに由来)

8粒

Method of consumption (original Japanese text)

1日8粒を目安に水またはお湯でお召し上がりください。

Ingredient names for daily quantities (original Japanese text)

グルコサミン塩酸塩

Declared daily quantities (original Japanese text)

1,500mg

A claim declared in Japan is not an authorised health claim in the European Union. See the health claims register.

Original register data

View published fields and their variants
Functional component amount
1,500mg
Functional component
グルコサミン塩酸塩
Published daily intake
8粒
Published designation
グルコサミン塩酸塩含有食品
Product name
・リフレのグルコサミンプレミアム
Published last update
2023/08/05
Reason for withdrawal
商品が終売になり在庫がなくなったため。
Publication date
2019/08/30
Notification number
E367
Published intake method
1日8粒を目安に水またはお湯でお召し上がりください。
Published precautions
原材料を参照の上、食物アレルギーのある方は、お召し上がりにならないでください。血液凝固阻止薬(ワルファリン等)をご使用の場合は、医師、薬剤師に相談してください。
Declared withdrawal
1
Withdrawal date
2025/03/20
Official scientific dossier
https://www.fld.caa.go.jp/caaks/s/cssc01/fwccd01?c__id=a09F900004sk8ViIAI
Functional component
グルコサミン塩酸塩
Company
株式会社リフレ
Claimed function in the source
本品に含まれるグルコサミン塩酸塩には、膝関節の可動域を広げて膝の曲げ伸ばしの動きを助け、膝の不快な違和感を和らげる機能が報告されています。
Product category
加工食品(錠剤、カプセル剤等)
Published marketing status
販売休止中
Functional component raw materials
原材料名:グルコサミン(えび・かに由来)

Official source

View the official register, number E367

Source : Agence de la consommation du Japon (CAA), https://www.fld.caa.go.jp/caaks/s/cssc01/. Données traitées par CompoAtlas à partir de l'export officiel ; cette présentation est celle de CompoAtlas et n'est pas publiée telle quelle par l'État japonais. Public Data License 1.0.

Public Data License 1.0 (公共データ利用規約 第1.0版), compatible CC BY 4.0

List in the official revision dated (register: CAA, Japan Foods with Function Claims notifications).

List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line